海正药业：公司及全资子公司3个产品拟中选第十一批全国药品集中采购

Core Viewpoint - Haizheng Pharmaceutical (600267) and its wholly-owned subsidiary, Hanhui Pharmaceutical Co., Ltd., participated in the 11th batch of national centralized drug procurement organized by the Joint Procurement Office, with three products expected to win bids in this procurement process [1] Group 1 - The company announced its participation in the national centralized drug procurement bidding on October 29 [1] - The Joint Procurement Office published the proposed winning results for the procurement on October 28, 2025 [1] - The three products that are expected to win bids include Pravastatin Sodium Tablets, Injection Adenosine Methionine, and Aicuo Bopamine Ethanolamine Tablets [1]